Return to Emergent BioSolutions

    08.17.2022

    How CDMOs Can Support Nanoparticles for Gene Therapy, Immuno-Oncology and Vaccines

    Nanoparticles have experienced increasing demand in recent years in biopharmaceutical formulations, owing to their utility for...

    READ MORE
    WANT MORE INFORMATION?

    Learn more about Emergent Bioservices' work and the many milestones we’ve reached in our news release archive below.  If you’re a media representative, please feel free to contact us at cdmo@ebsi.com.

    Interested in learning more about Emergent BioSolutions, Inc.? Please visit emergentbiosolutions.com.

    WANT MORE INFORMATION?

    Learn more about Emergent Bioservices work and the many milestones we’ve reached in our news release archive below.  If you’re a media representative, please feel free to contact us at mediarelations@ebsi.com.

    Interested in learning more about Emergent BioSolutions, Inc.? Please visit emergentbiosolutions.com.